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a transcriptome dataset where neutrophils were exposed in vitro to plasma of patients 23 with sepsis. However, no literature linking FAM129A and either neutrophils, sepsis or 24 inflammation could be identified. Additional datasets were selected to independently 25 validate this initial observation and further explore differential expression of FAM129A in 26 the context of sepsis studies. Follow on investigations carried out at the bench confirmed 27 restriction of the expression of FAM129A protein at the surface of circulating blood 28 neutrophils and monocytes. A potential role for FAM129A in neutrophil survival was 29 inferred from profiling of literature associated with FAM129A, which remains to be 30 investigated in further follow on investigations .  31   32   33   34   35   36  37  38  39  40  41  42  43  44  45  INTRODUCTION  46  47 Sepsis is a life-threatening condition characterized by multiple organ dysfunction [1] . 48
Understanding of the underlying pathogenic mechanism has greatly improved over the 49 past several years. Yet interventions aiming at modulating the exaggerated immune 50 response to infection, one of the root causes of sepsis complications, are yet to 51 materialize in clinical practice. Neutrophils constitute a first line of defense against 52 bacterial infections. This specialized population of leukocytes carries effector functions 53 via the production of immune mediators as well as through microbicidal activity, either 54 resulting from degranulation or through a process that is referred to as "netosis" which 55 consists in formation of extracellular traps that serve to immobilize and kill invading 56 pathogens [2] . 57
In earlier work we have demonstrated the singular ability of neutrophils to respond 58 to immunomodulatory factors present in the plasma of patients with severe sepsis ([3] / 59 GSE49758). This transcriptome dataset which at the time was deposited in the NCBI's 60 gene expression omnibus was employed more recently in the context of a training 61 workshop conducted at Sidra Medicine in Doha Qatar in November of 2018. Trainees 62 applied reductionist investigation approaches, using available public omics data as a 63 starting point (COD1 training module, as described in: [4] FAM129A levels are increased in neutrophils exposed to septic serum 106
The "primary" dataset used as a basis for identification of candidate genes was 107 generated and deposited in GEO by our team in the context of an earlier publication [3] . 108
In this experiment neutrophils were isolated from the blood of healthy individuals and 109 exposed in vitro for 6 hours to plasma from adult patients with sepsis. The neutrophil 110 transcriptional response was measured using Illumina beadarrays. FAM129A was 111 prioritized as a target for this training activity on the basis of: 1) increased abundance of 112 this transcripts following in vitro exposure of neutrophils to serum of septic patients 113 (GSE49758, [3]), and 2) the extent of the overlap between the FAM129A literature and 114 literature on sepsis, neutrophil or inflammation. Figure 1 shows levels of FAM129A 115 transcript abundance in neutrophils exposed to plasma from subjects with non-severe or 116 severe sepsis. Difference between these two groups was significant (p <0.01). 
Independent validation in silico 144
The third task assigned to the trainees was to validate the initial finding in 145 independent public datasets. GEO datasets relevant to sepsis or neutrophil 146 immunobiology were curated and uploaded on the custom GXB data browsing 147 application. This resource comprises 48 datasets and is available via this link: 148 http://sepsis.gxbsidra.org/dm3/landing.gsp. This GXB instance was created expressly in 149 support of the activities conducted in the context of workshops utilizing the same primary 150 dataset and pool of candidate genes (as described in a manuscript that is in preparation, 151 GXB has been previously described and is available on GitHub [5]). Trainees were asked 152 to: first select vdatasets that they estimated to be adequate for validation, on the basis of 153 the information about study/experimental design available in GXB or in the linked primary 154 publication, and, secondly, to access the profile of FAM129A in each of the dataset. This 155 two-step process was established to avoid biasing the validation process. In the case of 156 FAM129A, seven datasets were first selected in which abundance levels of transcript 157
were measured in whole blood, PBMCs or neutrophils of patients with sepsis (Table 1 ) 158
[7-13]. FAM129A transcript abundance was not measured in one of the datasets [13] . 159
Increase in FAM129A transcript levels in septic patient as compared to controls was found 160 in four of the six remaining datasets (Figure 3) . The characteristics of the study 161 populations varied, with three out of six consisting of pediatric subjects and the other three 162 of adults (Figure 4) . One study was conducted in Asia, one in Europe and four in North 163
America. Assay characteristics were also different since in four cases samples were run 164 on Illumina beadchips and in two on Affymetrix GeneChips. The datasets in which no 165 increases in levels of FAM129A were not observed were conducted both in adults and in 166 North America. One of them profiled whole blood and used Illumina arrays, while the other 167 profiled neutrophils and used Affymetrix arrays. In yet another dataset in which profiles 168 were generated via RNA sequencing increase in abundance of FAM129A could be 169 observed in whole blood of septic patients as well as in isolated monocytes but it was not 170 the case in neutrophils in which abundance levels were uniformly higher 171 The last COD1 assignment requires trainees to build inferences about the potential 184 role for the candidate gene in the context of the primary dataset/study in which the initial 185 observation was made. In order to support this process, the FAM129A literature was 186 profiled in order to identify the main functional "themes" associated with this molecule. 187
Keywords in titles in which FAM129A is mentioned were extracted, categorized and 188 recorded in a spreadsheet. Categories included: "biological processes", "disease", 9 "tissue", "biomolecules", etc… Subsequently, the prevalence of those keywords in the 190 FAM129A literature was determined. Top keyword or phrases included "thyroid 191 carcinoma" (10 articles out of the 35 constituting the FAM129A literature), which after 192 consolidation with related keyword/phrases such as "thyroid cancer", "follicular thyroid 193 neoplasms", "thyroid follicular tumors", "thyroid tumors" yielded a total of 12 entries. Other 194 major concepts associated with FAM129A were "apoptosis" (7 entries), "proliferation" (6 195 entries) and "renal tumors" OR "renal carcinogenesis" (5 entries). 196
Next, these top FAM129A-associated concepts were employed in order to 197 establish indirect relationships with the context of the primary study in which differential 198 FAM129A expression was observed. While only one article could be found connecting 199
FAM129A directly to either the sepsis, inflammation or neutrophil literature, many were 200 found which permitted to establish an indirect connection through via "thyroid cancer", 201 apoptosis or proliferation (Figure 6) . 202
The indirect associations established between FAM129A and sepsis, inflammation 203 and the neutrophil literature were next used as a framework to make inferences about the 204 role of FAM129A in this context as is outlined in the discussion. 205
206

DISCUSSION
208
While no literature describes the role of FAM129A in neutrophils and its relation to sepsis, 209 the biological concepts apoptosis and proliferation have previously been linked to 210 FAM129A. Expression of FAM129A has been frequently reported in human cancer, 211
including thyroid carcinoma, head and neck cancer and renal carcinoma [15] [16] [17] [18] [19] [20] [21] [22] [23] . In 212 human cancer cells, an anti-apoptotic role for FAM129A has been described [16, 24] . A 213 similar role for FAM129A could be possible in neutrophils. Neutrophils have a short life 214 span both in the circulation (8-20 hours) and in tissue (1-4 days). The constitutive 215 neutrophil death is a type of apoptotic death and its regulation is essential for neutrophil 216 homeostasis [25] . A prolonged lifespan of neutrophils has been linked to sepsis in patients 217 with burns, traumatic injuries and pneumonia [26] [27] [28] [29] . This could be an explanation for 218 the observed upregulation of FAM129A in neutrophils in association with sepsis or 219 increased severity of sepsis. Thus our hypothesis is that the inhibition of neutrophil Mol Med, 2011. 17(11-12) independent datasets. This graph shows fold changes in abundance of FAM129A in six 341 independent datasets selected for follow on investigation of the increase in abundance of 342 FAM129A RNA observed in neutrophils exposed to septic plasma (Figure 1 ). Each GSE54514 (also listed in Table 1 ). FAM129A transcript abundance profiles for each of 352 these datasets is plotted in Figure 3 . 
